| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |